Kentucky Opioid Abatement Advisory Commission to Hear Personal Testimonies Supporting $42 Million Funding for Ibogaine Research

September 15 hearing will feature personal stories from parents, veterans, and others who have used ibogaine to treat Opioid Use Disorder FRANKFORT, Ky., Sept. 13, 2023 /PRNewswire-PRWeb/ -- W. Bryan Hubbard, Chair and Executive Director of the Kentucky Opioid Abatement Advisory...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news